Introduction: The aim of this study was to analyze the effects of the rs9939609 (T/A) gene variant in fat mass and obesityassociated gene (FTO) on body weight changes after 3 years and its modification by a randomized nutritional intervention with a Mediterranean-style diet in a population of subjects at high cardiovascular risk. Design: A substudy of PREDIMED, which is a randomized trial aimed at assessing the effect of the Mediterranean diet (MD) for primary cardiovascular disease prevention. There were three nutritional intervention groups: two of them with a Mediterraneanstyle diet and the third was a control group advised to follow a conventional low-fat diet. Subjects: A total of 776 high cardiovascular risk subjects aged 55-80 years. Measurements: Anthropometric measurements were recorded at baseline and at 3 years. The participants were genotyped by RT-PCR, followed by allelic discrimination. Results: Homozygous subjects had the highest baseline body weight. The dominant model showed that subjects carrying the A allele had the lowest body weight gain (B ¼ À0.685; P ¼ 0.022) after 3 years of nutritional intervention compared with nonmutated subjects (TT genotype) regardless of the nutritional intervention. Moreover, this effect was statistically significant in carriers of the A allele only among those allocated to the MD groups (B ¼ À0.830; P ¼ 0.018), but it was not significant among those allocated to the control group (P for interaction ¼ 0.649). Conclusion: This study confirmed the association between body weight and the FTO rs9939609 polymorphism. Interestingly, our results showed that, although at baseline the A allele was associated with higher body weight, after 3 years of nutritional intervention with a Mediterranean-style-diet, A-allele carriers had lower body weight gain than wild type subjects. No interaction between nutritional intervention and the polymorphism was found.
Introduction
Common polymorphisms of the fat mass and obesityassociated gene (FTO) have been linked to obesity in several populations. [1] [2] [3] [4] One of these genetic variants (rs9939609), located within the first FTO intron, has been related to an increased risk for both type 2 diabetes mediated by body mass index (BMI) and obesity. 1 The role of FTO variants on body weight regulation is unclear. In adults and children, there are studies addressing the interaction between lifestyle influences and the FTO rs9939609 gene variant on body weight changes. [5] [6] [7] [8] [9] Most of the studies are based on cross-sectional data and are not allowed to establish any causal relationship. [10] [11] [12] Several studies have found that the effect of FTO gene variants on adiposity may depend on sex, physical activity or total energy intake. 10, 12, 13 However, few intervention studies have explored the interaction between lifestyle changes and FTO gene variant on adiposity indices or metabolic outcomes. [5] [6] [7] [8] [9] 14 Two studies performed on diabetic subjects did not find any association. 8, 9 To explore the possible contribution of diet as an effect modifier on the role of rs9939609 FTO gene variant on body weight changes, long-term nutritional intervention trials are necessary. The Mediterranean dietary pattern has been associated with a lower risk of obesity or weight gain. [15] [16] [17] [18] An important characteristic of this dietary pattern is that it is based on a relatively high fat intake, which is particularly rich in mono and polyunsaturated fatty acids and low in saturated fat. 19 The PREDIMED trial is a long-term randomized trial to assess the effects of a Mediterranean-style diet on the prevention of cardiovascular disease (CVD). 20, 21 Our aim was to analyze the effects of the rs9939609 FTO gene polymorphism on body weight changes after 3 years of a Mediterranean-style diet in a high cardiovascular risk population.
Subjects and methods

Study population
This study has been conducted within the frame of the PREDIMED trial. The design of the PREDIMED trial has been reported in detail elsewhere. 20, 22 Briefly, the PREDIMED trial is a large, parallel-group, multicenter, randomized and controlled 4-year clinical trial that aims to assess the effects of a Mediterranean-type diet on CVD, in which participants are assigned to one of three different dietary patterns: low-fat diet; Mediterranean diet (MD) supplemented with virgin olive oil (MD þ VOO); and MD supplemented with nuts (MD þ Nuts). 20, 23 The study population is composed of men aged between 55 and 80 years and women aged between 60 and 80 years with no previously documented CVD, but at high cardiovascular risk. Inclusion criteria were either diabetes mellitus type 2 or at least three of the following risk factors: current smoking, hypertension, hyperlipidemia, high-density lipoprotein (HDL)-cholesterol o1.034 mM, overweight/obesity or family history of premature coronary heart disease. We included data from 776 participants enrolled in the AP-UNAV recruitment center in Pamplona (total number of participants: 1055), in which the retention rate during the third year was greater than 80%. Ninety-eight subjects were excluded from this study because we were unable to obtain DNA samples or their adiposity measures at year 3 were not recorded.
Statement of ethics
All participants provided informed consent to a protocol approved by the local ethical review boards.
Dietary assessment
The dietary habits of participants, both at baseline and after follow-up for 24 months, were assessed using a semiquantitative 137-item food frequency questionnaire previously validated in Spain. 24 More details about the dietary assessment are described elsewhere. 20 
Genotyping
Overnight fasting venous blood samples were collected in ethylenediaminetetraacetic acid-added tubes. DNA was extracted from the buffy coat fraction using a commercial kit (Master PureTM; Epicentre, Madison, WI, USA). All subjects were genotyped for the rs9939609 polymorphism of the FTO gene using Taqman SNP allelic discrimination by means of an ABI PRISM 7000. The probes and primers for this assay were designed by Applied Biosystems (Madrid, Spain). Replicate quality control samples were included in every genotyping plate with more than 99% of concordance.
Statistical analysis
A w 2 test was used to evaluate the Hardy-Weinberg equilibrium. The Kolmogorov-Smirnov test was used to determine variable distribution. Descriptive analyses of variables between the three interventional groups were performed using parametric tests (Student's t-tests, analysis of variance, followed by Bonferroni's post hoc tests). Regarding statistical power, assuming a two-tailed alpha error of 0.05 to be able to detect a difference less than 1 kg (standard deviation ¼ 3.5), two equally sized groups, each consisting of 200 individuals (n ¼ 200), would achieve a statistical power of 81.5%. Statistical power was calculated using conventional formulas with the power analysis software, PS Power and Sample Size Calculations.
The effects of the polymorphism and nutritional intervention on body weight changes were evaluated with multivariate linear regression models after adjusting for relevant variables such as age, sex (male as the reference category), baseline BMI and diabetes. Two different models for the additive model (TT, AT and AA genotypes separately) and the dominant model (TT vs AT þ AA) of the polymorphism were fitted. Nutritional intervention was considered as three categories (control, MD þ VOO and MD þ Nuts), taking the control group as reference.
To analyze the effects of the polymorphism in MD groups compared with control subjects, two different linear regression models were carried out: one for the control group and the other for the two MD groups (VOO þ Nuts merged together). These models were adjusted for age, sex, baseline BMI and diabetes.
Moreover, to analyze the potential interactions between the polymorphism and nutritional intervention, an interaction product term was included in the model. The interaction product term FTO Â Mediterranean was defined Body weight change, FTO, Mediterranean diet C Razquin et al as (control group ¼ 0, MD groups merged together ¼ 1) Â (TT ¼ 0, TA and AA merged together ¼ 1). Thus, we considered the two MD intervention groups together, with the control group as the single reference group. An F partial test was conducted to study the improvement in the model when interaction product terms were included.
The effects of diabetes on body weight changes were analyzed in two different models: one for diabetics and the other for nondiabetics. These multiple regression models were adjusted for age, sex and baseline BMI, and included nutritional intervention (control group as the reference) and the polymorphism (additive and dominant models).
Results
Characteristics of participants according to nutritional group at baseline and at year 3 of intervention are shown in Table 1a . Owing to randomization, there were no significant differences in any of the biological variables between the three nutritional groups at the beginning of the study (Table 1a ). Total energy intake was significantly higher in both MD groups at baseline and after 3 years of study. Total fat, mono-and polyunsaturated fat intakes were significantly higher in both MD groups than in the control group (Po0.001), whereas the ratio of saturated to total fat was significantly higher in the control group (data not shown). Mean body weight changes were similar among the three nutritional groups.
The distribution of genotypes for the rs9939609 polymorphism of the FTO gene variant was in Hardy-Weinberg equilibrium in the study population, with a minor A-allele frequency of 0.45. The characteristics of participants according to genotype (TT, TA or AA) are presented in Table 1b . Homozygous subjects for the polymorphism (AA) had significantly higher body weight compared with heterozygous (TA) subjects (P ¼ 0.049) and borderline was significantly higher compared to wild type (TT) subjects (P ¼ 0.058). In contrast, AA subjects had the lowest body weight gain, À0.57 kg (P ¼ 0.016) compared with wild type subjects. Moreover, TA subjects presented a statistical tendency to have lower body weight compared with wild type subjects (P ¼ 0.056). Taking these results into account, we decided to analyze the polymorphism both as an additive model (TT vs TA vs AA) and as a dominant model (TT vs TA þ AA).
To better screen the effects of nutritional intervention and the polymorphism on body weight changes, a linear regression model adjusted for age, sex, baseline BMI and diabetes was fitted ( Table 2 ). The additive model of rs9939609 (Table 2a) showed that subjects with the lowest Body weight change, FTO, Mediterranean diet C Razquin et al body weight gain were homozygous subjects (AA) (B ¼ À0.936; P ¼ 0.022). Heterozygous subjects for the polymorphism tended to have lower body weight gain than nonmutated subjects (B ¼ À0.581; P ¼ 0.069). Although the differences between nutritional groups were not statistically significant, both MD groups, especially MD þ VOO, seemed to have decreasing body weight change. Similar results were obtained in a logistic regression model taking body weight gain X2 kg as the dependent variable. In that analysis, we observed that homozygous subjects (AA) were protected against gaining X2 kg (odds ratio ¼ 0.588; P ¼ 0.028) (data not shown).
The linear regression analysis for the dominant model (Table 2b) showed that subjects carrying the A allele had the lowest body weight gain compared with nonmutated subjects (B ¼ À0.685; P ¼ 0.022). This model showed that, as in the additive model, MD groups seemed to have a lower body weight gain, although it was not statistically significant.
As the results suggested that MD groups may decrease body weight gain, we decided to analyze whether there was an interaction between the polymorphism and Mediterranean diet. The multiple regression model (dominant) did not improve when an interaction product term (polymorphism and MD) was added (F ¼ 0.43; P ¼ 0.65). The interaction considering the additive model was also nonsignificant (P for interaction ¼ 0.660). Therefore, another approach was to merge both MD groups (VOO þ Nuts) together and analyze the effect of the polymorphism separately from the control group. Table 3 showed multiple regression models assessing the effects of the rs9939609 polymorphism on body weight changes within MD groups in additive (Table 3a) and dominant models (Table 3b ). The additive model showed that heterozygous subjects (TA) were predicted to have lower body weight gain after 3 years of nutritional intervention with MD (B ¼ À0.796; P ¼ 0.033). Homozygous subjects for mutation (AA) presented a tendency to have lower body weight gain compared with type subjects (B ¼ À0.914; P ¼ 0.057). The dominant model Body weight change, FTO, Mediterranean diet C Razquin et al showed that subjects carrying the A allele had significantly lower body weight (B ¼ À0.830; P ¼ 0.018) compared to wild type subjects (TT) after 3 years of intervention with MD (both with high intake of VOO or nuts).
Owing to the fact that the FTO gene variant seems to be involved in diabetes mediated by the effect on BMI, we decided to study whether the effect of the rs9939609 polymorphism on body weight change after 3 years of nutritional intervention was affected by the presence of diabetes. Multiple regression models for the study of body weight change were fitted among nondiabetics (n ¼ 500) and diabetics (n ¼ 278). For diabetic patients, the model that better described the effects of the polymorphism was the dominant model (Table 4) and was adjusted for age, sex and BMI. It showed that subjects carrying the A allele had statistically lower body weight gain than wild type subjects (B ¼ À1.123; P ¼ 0.036). The same model for nondiabetics showed the same tendency but results were not statistically significant (B ¼ À0.418; P ¼ 0.245) (data not shown).
Moreover, we observed in the multiple regression models assessing body weight changes that baseline BMI was significantly associated with a reduction in body weight gain (Po0.001 for all the models).
Discussion
Our results confirm the association between the common FTO variant rs9939609 and body weight in a long-term nutritional intervention study with a Mediterranean-style diet. Although at baseline it seemed that AA subjects were those with the highest body weight, after 3 years of nutritional intervention, these subjects had the lowest body weight gain.
Owing to recent knowledge of the association between polymorphisms on the FTO gene and obesity, 1, 2, 25 there are some cross-sectional studies confirming the association, 3, 4, 26, 27 but there is a lack of information about the influence of lifestyle factors on this association in intervention studies. 8, 9, 11 To the best of our knowledge, this is the first study that analyzes the effects of a Mediterranean-style diet on the interface FTO gene variants and body weight regulation. The A allele of the rs9939609 polymorphism has been associated with higher body weight and higher rates of obesity. 1, 9 In fact, in our study, the baseline body weight measurement revealed that subjects with the AA genotype were those with the highest body weight. Interestingly, we found a robust association between A allele and body weight reduction after 3 years in the intervention program. This finding suggests a potential role of diet in the link between FTO and body weight. The A-allele carriers of the control (low fat) or MD groups had lower body weight gain compared with the nonmutated (TT) group, but it seems that both MD groups (VOO or Nuts) had lower body weight gain than did control subjects. We confirmed the implication of dietary pattern in this relationship between FTO gene variant and body weight change. Specifically, the lowering body weight effect of carrying the A allele was significantly higher among subjects allocated to MD groups. It seems that having a conventional low-fat diet is beneficial for subjects carrying the A allele of the rs9939609 polymorphism, but it seems to be even better to follow a Mediterranean-style diet. Therefore, changes in the dietary macronutrient composition, but not in total energy intake, may interact with the polymorphism and confer to A-allele carriers some protection against body weight gain. Indeed, there are investigations reporting interactions of dietary fat with some gene variants. [28] [29] [30] [31] [32] Moreover, a recent report 33 suggested that rs9939609 of the FTO polymorphism may modify resting energy expenditure, depending on fat intake. In this sense, we could speculate that a Mediterranean-based diet (rich in mono-and polyunsaturated fat) could change the effects of FTO on energy expenditure. Further studies are necessary to confirm our results. The interventional studies in adult populations analyzing the interactions between lifestyle and FTO gene variants on body weight changes were conducted in diabetic risk patients, but did not find any association. 8, 9 However, in our study, we observed that diabetic subjects carrying the A allele had the lowest weight gain, suggesting a potential link between the FTO gene variant, body weight change and diabetes. In this sense, Shai et al. 18 reported that a 2-year Mediterranean-style diet, designed to lose weight, was associated with an improvement in plasma glucose and insulin levels in diabetic patients. This finding suggested that it may be that MD could also be affecting the link between FTO gene variant, body weight and diabetes in our population by its influence on body weight changes. 
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No sex effect on the relationship between FTO polymorphism and body weight changes was found in our population. In literature, Jacobsson et al. 13 have suggested a sex-dependent effect of the FTO gene variant on body weight, but it was not confirmed by other authors. 5, 9 Similarly, some studies have shown a significant interaction between rs9939609 FTO and physical activity on BMI. 10, 12 We did not observe any significant effect of physical activity, maybe because of the low levels of physical activity in our high cardiovascular risk population having a mean age of 68 years. In recent interventional studies, Lappalainen et al. and Franks et al. 8, 9 did not report any effect in younger populations ( ± 50 years).
On the other hand, we observed in the regression models analyzing the effects of the polymorphism and nutritional intervention that higher the baseline BMI higher is the body weight gain reduction. This finding has been previously reported in other studies. 34, 35 In conclusion, this study confirmed the association between body weight and the FTO rs9939609 polymorphism. Moreover, these results showed that, although at baseline the A allele was associated with higher body weight, after 3 years of nutritional intervention with a Mediterranean-style-diet, A-allele carriers had the highest body weight reduction. An interaction between nutritional intervention and the polymorphism was not found.
